| AAMIAcadian Asset Management Inc. |
US$ 563,7 mi |
14,2% |
2025 |
| ACELAccel Entertainment, Inc. |
US$ 1,3 bi |
3,9% |
2025 |
| ARXAccelerant Holdings |
US$ 912,9 mi |
-156,1% |
2025 |
| ACNAccenture plc |
US$ 69,7 bi |
11,0% |
2025 |
| ACCLAcco Group Holdings Ltd |
US$ 4,9 mi |
20,9% |
2025 |
| ASIIAccredited Solutions, Inc. |
US$ 688,9 mil |
-216,1% |
2023 |
| ACUTAccustem Sciences Inc. |
n/d |
n/d |
2025 |
| ACONAclarion, Inc. |
US$ 75,7 mil |
-9.551,9% |
2025 |
| ACRSAclaris Therapeutics, Inc. |
US$ 7,8 mi |
-829,6% |
2025 |
| ACRVAcrivon Therapeutics, Inc. |
n/d |
n/d |
2025 |
| ATNMActinium Pharmaceuticals, Inc. |
US$ 90 mil |
-37.652,2% |
2025 |
| AEAQActivate Energy Acquisition Corp. |
n/d |
n/d |
n/d |
| ABOSAcumen Pharmaceuticals, Inc. |
n/d |
n/d |
2025 |
| ACXPAcurx Pharmaceuticals, Inc. |
n/d |
n/d |
2025 |
| GOLFAcushnet Holdings Corp. |
US$ 2,6 bi |
7,4% |
2025 |
| ADAGAdagene Inc. |
US$ 7,7 mi |
-229,6% |
2025 |
| ADGMAdagio Medical Holdings, Inc. |
US$ 0 |
n/d |
2025 |
| AHCOAdaptHealth Corp. |
US$ 3,2 bi |
-2,2% |
2025 |
| ADTIAdapti, Inc. |
n/d |
n/d |
n/d |
| ADAPYAdaptimmune Therapeutics PLC |
US$ 178 mi |
-39,8% |
2024 |
| ADPTAdaptive Biotechnologies Corp |
US$ 277 mi |
-21,5% |
2025 |
| ADOOYAdaro Energy PT |
n/d |
n/d |
n/d |
| ADXNAddex Therapeutics Ltd. |
CHF 404,1 mil |
1.746,0% |
2024 |
| ADDTFAddtech AB |
n/d |
n/d |
n/d |
| ADUSAddus HomeCare Corp |
US$ 1,4 bi |
6,7% |
2025 |
| AGROAdecoagro S.A. |
US$ 1,5 bi |
6,1% |
2024 |
| ADEAAdeia Inc. |
US$ 443,4 mi |
25,1% |
2025 |
| ADIAAdia Nutrition, Inc. |
US$ 700,5 mil |
-56,5% |
2025 |
| ACETAdicet Bio, Inc. |
n/d |
n/d |
2025 |
| ADNTAdient plc |
US$ 14,5 bi |
-1,9% |
2025 |
| ADTXAditxt, Inc. |
US$ 3,2 mil |
-1.349.028,2% |
2025 |
| ANLAdlai Nortye Ltd. |
n/d |
n/d |
2024 |
| ADSEAds-Tec Energy Public Ltd Co |
€ 110 mi |
-89,0% |
2024 |
| ASIXAdvanSix Inc. |
US$ 1,5 bi |
3,2% |
2025 |
| ADVBAdvanced Biomed Inc. |
n/d |
n/d |
2025 |
| AFCGAdvanced Flower Capital Inc. |
US$ 24,6 mi |
-85,7% |
2025 |
| ADVAdvantage Solutions Inc. |
US$ 3,5 bi |
-6,4% |
2025 |
| ADBTAdvasa Holdings, Inc. |
n/d |
n/d |
n/d |
| ADYYFAdyen N.V. |
n/d |
n/d |
n/d |
| AEBIAebi Schmidt Holding AG |
US$ 1,5 bi |
0,6% |
2025 |
| AEGXFAecon Group Inc. |
n/d |
n/d |
n/d |
| ALMUAeluma, Inc. |
US$ 4,5 mi |
-205,3% |
2026 |
| ANNSFAena S.A. |
n/d |
n/d |
n/d |
| AESPAeon Acquisition I Corp. |
n/d |
n/d |
n/d |
| AERAerCap Holdings N.V. |
US$ 8,5 bi |
44,0% |
2025 |
| ASLEAerSale Corp |
US$ 335,3 mi |
2,6% |
2025 |
| AERTAeries Technology, Inc. |
US$ 70 mi |
4,0% |
2026 |
| AVAVAeroVironment Inc |
US$ 2 bi |
-13,4% |
2026 |
| PAIYYAesthetic Medical International Holdings Group Ltd |
CN¥ 755,7 mi |
-2,6% |
2024 |
| ATHRAether Holdings, Inc. |
US$ 1,4 mi |
-227,5% |
2025 |